Skip to main content
. 2016 Aug 31;12(4):2563–2567. doi: 10.3892/etm.2016.3639

Figure 3.

Figure 3.

Effects of GRb1 on the activity of intestinal MPO. Results are presented as mean ± standard deviation. *P<0.05, vs. CG, #P<0.05, vs. PG. GRb1, ginsenoside Rb1; MPO, myeloperoxidase; CG, control group; PG, peritoneal air exposure for 3 h group; GG5, 5 mg/kg GRb1-treated PG group; GG10, 10 mg/kg GRb1-treated PG group; GG20, 20 mg/kg GRb1-treated PG group.